跳至主要内容
临床试验/IRCT20181219042047N2
IRCT20181219042047N2招募中3 期

The effect of bromelain supplementation on oxidative stress, inflammatory markers and clinical outcomes in patients with traumatic brain injury admitted to the intensive care unit of Besat hospital

Artesh University of Medical Sciences0 个研究点目标入组 58 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
58

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Patients with moderate to severe traumatic brain injury hospitalized in the intensive care unit, 7=GCS=12
  • Age range from 18 to 65 years
  • Stability of hemodynamic and metabolic status in the first 24 to 48 hours
  • Having nutritional support for the patient through gavage
  • Willingness to cooperate and sign the informed consent form after being fully informed about the objectives and method of conducting the study by the person herself or her legal guardian.

排除标准

  • Having an underlying cancer disease, autoimmune diseases, congenital metabolic diseases, acute or chronic liver failure, chronic kidney failure, and acute kidney failure if the patient needs dialysis
  • pregnancy and breastfeeding
  • history of known food allergy
  • Unwillingness to participate in the study
  • suffering from sepsis or any acute or chronic infection
  • allergy to supplements

研究者

发起方
Artesh University of Medical Sciences

相似试验